Given the following molecule represented by the SMILES string: CCN=c1nc(N(C)C)nc(Oc2ccc(=O)n(-c3ccccc3)n2)[n-]1, and the following genes: ABCB1,ABL1,ADRA1D,ADRA2B,ADRB2,CA12,CA2,CA9,CACNA1H,CDK2,CHRM1,CHRM3,CHRM4,CNR1,CYP1A2,CYP2C19,CYP2C9,CYP2D6,CYP3A4,DRD2,DRD3,DRD4,EGFR,ESR1,FLT1,HRH1,HTR1A,HTR2A,HTR2B,HTR2C,HTR6,KCNH2,KDR,LCK,MCL1,OPRK1,PPARG,PTGS1,SIGMAR1,SLC6A2,SLC6A4, describe whether the molecule is related to one or a few of these genes in clear, simple and accurate English. Explain the relationship between the molecule and the related genes in detail. You can break down by explain the patterns of the molecule, followed by the gene features. Format the output as 'Step 1:', 'Step 2:', etc., with each step focusing on a specific aspect of the molecule's structure or properties. Finally, summarize the related gene names in a list. Limit the reasoning to at most 5 steps. You can stop after summarizing the related gene names. Step 1: The provided SMILES string represents a complex organic molecule, likely a drug-like compound with potential pharmacological activity. The molecule contains several functional groups such as amide (N-C=O), ester (O-C=O), and aromatic rings (e.g., benzene rings). These features suggest the molecule could interact with proteins that bind or catalyze reactions involving these functional groups.
Step 2: Considering the functional groups and the presence of a nitrogen-containing heterocycle (possibly an imidazole or similar ring), this molecule might have affinity for receptors or enzymes that recognize and bind to similar structures. This includes G-protein coupled receptors (GPCRs) and cytochrome P450 enzymes, which are known to be involved in drug metabolism and signaling pathways.
Step 3: Among the listed genes, those encoding for GPCRs and enzymes involved in drug metabolism are particularly relevant. For instance, GPCRs such as DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, CHRM1, CHRM3, CHRM4, and HRH1 could potentially interact with the molecule due to its structural features. Additionally, genes like CYP2C19, CYP2C9, CYP2D6, and CYP3A4 encode enzymes involved in the metabolism of many drugs, including this molecule.
Step 4: The moleculeâ€™s structure also suggests potential interactions with ion channels, such as KCNH2, which encodes for a potassium voltage-gated channel, as well as other genes involved in neurotransmitter transport or signaling, such as SLC6A2, SLC6A4, and PTGS1 (COX2).
Step 5: Summary of related genes: DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, CHRM1, CHRM3, CHRM4, HRH1, CYP2C19, CYP2C9, CYP2D6, CYP3A4, KCNH2, SLC6A2, SLC6A4, PTGS1. 
These genes are associated with neurotransmission, receptor binding, and metabolic processes that could be influenced by the described molecular structure. Further detailed studies would be required to confirm specific interactions and biological activities. 
Summary of related genes: DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, CHRM1, CHRM3, CHRM4, HRH1, CYP2C19, CYP2C9, CYP2D6, CYP3A4, KCNH2, SLC6A2, SLC6A4, PTGS1. 
Note: This summary does not include all possible genes but focuses on those most likely to interact with the described molecule based on its structural features. Additional genes may also be relevant depending on the specific biological context and mechanisms of action.
